Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 19, 2020 - Issue 1
Submit an article Journal homepage
475
Views
12
CrossRef citations to date
0
Altmetric
Drug safety evaluation

Evaluation of safety for flibanserin

Anita H Claytona Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USACorrespondence[email protected]
View further author information
,
Louise Brownb Sprout Pharmaceuticals Raleigh, NC, USAView further author information
&
Noel N Kimc Institute for Sexual Medicine, San Diego, CA, USAView further author information
Pages 1-8 | Received 16 Oct 2019, Accepted 18 Dec 2019, Published online: 23 Dec 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani & Barbara Gardella. (2023) Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?. Expert Opinion on Pharmacotherapy 24:1, pages 135-143.
Read now
Marianne J. Naguib & Amal I. A. Makhlouf. (2021) Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study. Drug Delivery 28:1, pages 1301-1311.
Read now

Articles from other publishers (10)

Mohamed I. Ahmed, Heba M. A. Abdelrazek, Yasser M. Moustafa, Samar Z. Alshawwa, Maysa A. Mobasher, Basel A. Abdel-Wahab, Fathy Elsayed Abdelgawad & Dina M. Khodeer. (2023) Cardioprotective Effect of Flibanserin against Isoproterenol-Induced Myocardial Infarction in Female Rats: Role of Cardiac 5-HT2A Receptor Gene/5-HT/Ca2+ Pathway. Pharmaceuticals 16:4, pages 502.
Crossref
Franklin José Espitia De La Hoz. (2023) Eficacia y seguridad de la testosterona en el tratamiento del deseo sexual hipoactivo en mujeres: ¿qué dice la evidencia?. Revista Internacional de Andrología 21:1, pages 100328.
Crossref
Claire S. Burton & Kavita Mishra. (2022) Pharmacologic therapeutic options for sexual dysfunction. Current Opinion in Obstetrics & Gynecology 34:6, pages 402-408.
Crossref
Alan W. Shindel. (2022) Commentary on Simon et al. Sexual Medicine 10:6, pages 100586-100586.
Crossref
James A. Simon, Anita H. Clayton, Irwin Goldstein, Sheryl A. Kingsberg, Marla Shapiro, Sejal Patel & Noel N. Kim. (2022) Response to Commentary by Spielmans. Sexual Medicine 10:6, pages 100585.
Crossref
James A. Simon, Anita H. Clayton, Irwin Goldstein, Sheryl A. Kingsberg, Marla Shapiro, Sejal Patel & Noel N. Kim. (2022) Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder. Sexual Medicine 10:6, pages 100570-100570.
Crossref
Suneela Vegunta, Carol L. Kuhle, Jennifer A. Vencill, Pauline H. Lucas & Dawn M. Mussallem. (2022) Sexual Health after a Breast Cancer Diagnosis: Addressing a Forgotten Aspect of Survivorship. Journal of Clinical Medicine 11:22, pages 6723.
Crossref
James G. Pfaus. (2022) Politics of Sexual Desire. Current Sexual Health Reports 14:3, pages 71-81.
Crossref
Rossella E. Nappi, Lara Tiranini, Ellis Martini, David Bosoni, Alessandra Righi & Laura Cucinella. (2022) Medical Treatment of Female Sexual Dysfunction. Urologic Clinics of North America 49:2, pages 299-307.
Crossref
James A. Simon, Anita H. Clayton, Noel N. Kim & Sejal Patel. (2022) Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin. Sexual Medicine 10:1, pages 100476-100476.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.